Discover the Glaucoma Treatment Market lucrative opportunities by 2028

 The recent years have recorded an increase in the rollout of advanced products for the glaucoma treatment worldwide. Several contenders operating in the glaucoma treatment industry are depicting a keen interest in the adoption of various strategies for securing a robust competitive edge.

For instance, in November 2021, Alcon- an American Swiss company engaged in eye care products- announced the acquisition of Ivantis. This deal is expected to enable the former to integrate an effective product information into its glaucoma portfolio worldwide.

AERIE Pharmaceuticals, Inc., Cipla Inc., Bausch & Lomb Incorporated, Santen Pharmaceutical Co., Ltd., Novartis AG, Pfizer Inc., Inotek Pharmaceuticals, and others are some of the leading companies in the industry.

To access a sample copy or view the market report in detail along with the table of

contents, please click the link below: https://www.gminsights.com/request-sample/detail/5210

According to a recent study conducted by Global Market Insights Inc., glaucoma treatment market size is expected to surpass USD 7 billion by 2028. Here are a few major developments that are expected to drive the business landscape over the ensuing years:

1# Increasing collaborations in North America

The region of North America has registered an increase in partnership agreements by regional industry players for ensuring product penetration across various countries. For instance, in April 2021, Alcon inked an agreement for the acquisition of exclusive U.S. commercialization rights to Novartis’ Simbrinza 1%/0.2%.

Following the closure, the two companies would begin a transition period. During the same, Novartis would continue the sale of Simbrinza and the transfer of net profit to Alcon.

Browse key industry insights spread across 160 pages with 92 market data tables & 13 figures & charts from the report, “Glaucoma Treatment Market Statistics By Disease Type (Open Angle Glaucoma, Angle Closure Glaucoma), Drug Class (Prostaglandin Analogs, Beta Blockers, Adrenergic Agonists, Carbonic Anhydrase Inhibitors), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/glaucoma-treatment-market

Some of the major developments that are poised to impel the business landscape have been briefed below:

2# Growing product development initiatives in the Asia Pacific

The Asia Pacific glaucoma treatment market share accounted for more than 31% of the overall industry revenue in 2021 and will exhibit lucrative growth through 2028. This upsurge can be credited to the mounting number of product development activities by various organizations.

For example, in November 2021, a National University Health System team in Singapore developed a new glaucoma implant called the Paul Glaucoma Implant (PGI). The solution was designed for reducing patients’ eye pressure for a longer period, decreasing the reliance on eye drops.

The innovation helped in advancing the treatment of glaucoma owing to its higher safety profile and efficacy in the reduction of IOP.

3# Rising interest of medical institutions in research studies

Numerous medical organizations are undertaking various research initiatives for the production of effective treatments. These studies are expected to pave way for a pool of innovations across the glaucoma treatment market.

Quoting an example, in October 2021, researchers at the Northwestern University Fienberg School of Medicine published their findings, potentially producing an effective glaucoma treatment. The study was conducted using mice models for the identification of novel treatment targets.

The research helped in the discovery of a potential new class of glaucoma treatment for the most common form of the illness in adults. Similar studies are poised to favor the business scenario across various regions.

To sum up, the glaucoma treatment industry is expected to witness the integration of advanced technologies like novel IOP-lowering medications and combination therapy. These advancements are set to open doors to significant business opportunities through the coming years.

Partial Table of Contents (ToC) of the report:

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    MEA

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Glaucoma treatment industry 360° synopsis, 2017 – 2028

2.1.1    Business trends

2.1.2    Disease type trends

2.1.3    Drug class trends

2.1.4    Distribution channel trends

2.1.5    Regional trends

Chapter 3   Glaucoma Treatment Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing prevalence of glaucoma disease worldwide

3.3.1.2    Technological advancements in therapeutic interventions

3.3.1.3    Rising patient pool of geriatric population across the globe

3.3.1.4    Increasing ongoing clinical trials and product launches for glaucoma treatment

3.3.1.5    Increasing awareness initiatives regarding eye care in underdeveloped and developing nations

3.3.2    Industry pitfalls and challenges

3.3.2.1    Side effects associated with the drugs

3.3.2.2    Stringent product approval process

3.4    Growth potential analysis

3.4.1    By disease type

3.4.2    By drug class

3.4.3    By distribution channel

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2021

3.7.1    Competitive matrix analysis, 2021

3.8    PESTEL analysis

Browse complete table of content of this report@ https://www.gminsights.com/toc/detail/glaucoma-treatment-market

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com 
Web: https://www.gminsights.com/industry-reports/healthcare-and-medical-devices